Sign in
CompletedNo phase

A Study of Myofunctional Therapy After Sleep Apnea Surgery

Key facts

Who runs it
Taipei Medical University Shuang Ho Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
51 people enrolled
Started
1 Jan 2020
Ended
1 Jan 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • myofunctional therapy
Record updated
17 November 2025

Who can take part

Age
20 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Age 20-65 years
  • Moderate-to-severe Obstructive Sleep Apnea (AHI ≥ 15 events/hour) confirmed by PSG
  • Friedman palate position grade I-II and tonsil size grade III-IV
  • Patients who refuse or are unable to tolerate CPAP

Who cannot take part

  • Severe cardiopulmonary disease or psychiatric illness
  • Pregnancy or cancer
  • - Central or mixed sleep apnea
  • BMI > 27 kg/m²
  • Significant weight gain during the follow-up period

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent upper airway collapse. While surgery is a common treatment, its success rates are variable. Myofunctional therapy (MFT), a program of targeted oropharyngeal exercises, has emerged as a promising adjunctive treatment to improve surgical outcomes.

Read full original descriptionShow less

This study prospectively compared outcomes in adult patients with moderate-to-severe OSA who received postoperative MFT (OP+MFT) versus those who underwent surgery alone (OP). Following surgery, patients were allocated to either the OP+MFT group, which began a 12-week MFT program, or the OP-only group. Polysomnography (PSG) was performed at baseline and at 3 and 12 months post-surgery.

The study found that the OP+MFT group showed significantly greater improvements in key sleep parameters, including the Apnea-Hypopnea Index (AHI) and lowest oxygen saturation, compared to the OP group. These benefits were most pronounced at the 3-month follow-up, supporting the conclusion that postoperative MFT is a safe and effective adjunct to surgery for OSA.

The 2 groups in the trial

  • OP+MFT GroupTreatment being tested

    Participants in this group underwent surgery and began a structured 12-week postoperative myofunctional therapy (MFT) program starting at the third postoperative week.

    Treatment: myofunctional therapy

  • OP-only GroupNo study treatment, for comparison

    Participants in this group underwent the same surgical procedure but received only routine postoperative follow-up without any additional MFT training.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Postoperative Myofunctional Therapy Enhances Surgical Outcomes in Patients With Obstructive Sleep Apnea: A Prospective Comparative Stud
Record updated
17 November 2025